Alpine Immune Sciences Reports First Quarter 2023 Financial Results

Author's Avatar
May 11, 2023

Alpine+Immune+Sciences%2C+Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today reported financial results for the first quarter ended March 31, 2023.